Clinical Trial Update: Exercise During Chemotherapy for Patients With Hematological Malignancies [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating exercise during chemotherapy for hematologic diseases and hematologic malignancies; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Diseases
• Hematologic Malignancies

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Hematological Diseases, Hematological Malignancies | Phase 3 | Status: UNKNOWN